Kwality Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹3,630.30
+177.90+5.15% (1D)
As on 21 Aug 2026 at 05:50
As of 21 Aug 2026 at 05:50, Kwality Pharmaceuticals Ltd is trading at ₹3,630.30, with a market cap of ₹3.76 thousand crore. At a P/E of 46.10 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

KPL Price Chart

Market Cap
₹3.76K Cr
PE Ratio
46.10
ROCE
21.37%

Kwality Pharmaceuticals Ltd Performance

Kwality Pharmaceuticals Ltd Fundamentals

Market Cap₹3.76K Cr
ROE20.20%
P/E Ratio (TTM)46.10
EPS (TTM)₹78.68
P/B Ratio11.32
Dividend Yield0.00%
Industry P/E92.64
Book Value₹320.51
Debt to Equity0.39
Face Value₹10

Kwality Pharmaceuticals Ltd Shareholding Pattern

Promoter54.9%
Foreign Institutions3.1%
Mutual Funds0%
Domestic Institutions0.6%
Public41.4%

Kwality Pharmaceuticals Ltd Financial Statements

No data for this view.

Kwality Pharmaceuticals Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,901.00
1.00(+0.05%)
4,56,113.61,548.0 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,994.90
-18.10(-0.36%)
1,89,989.9
Cipla Ltd
₹1,437.65
15.65(+1.10%)
1,16,141.0
Lupin Ltd
₹2,203.10
-21.90(-0.98%)
1,00,732.9
Dr Reddys Laboratories Ltd
₹1,181.35
11.35(+0.97%)
98,604.4

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 56 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables. The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce. Certified as ISO: 9001:2015 and ISO 14001:2015, it is working with new SCHEDULE M and WHO norms and certified with GMP. The Company is keeping all records of inputs used in manufacturing. The inputs are tested as per standard laid down by company SOP. The in-process testing records are also maintained as per SOP. Similarly, finished goods are also tested as per SOP and are then allowed for sale. Apart from these, the Company is making medicines in various dosage forms like Liquid Orals, Powder for Oral Suspension, Tablets, Capsules, Dry Syrup, Syrup, Sterile Powder for Injections, small volume injectables, Ointments, External Preparations, ORS and many more in various categories like Beta Lactam & non-Beta Lactam, Hormones, Cytotoxic (Oncology) and Effervescent as per new GMP norms. Besides, it manufacture the latest drugs for the management of viral infections/diseases in different dosage forms. Each category of product is processed in a separate section, which is equipped with the latest machinery. All sections are supported by a centralized quality control department which has different segments. Each segment is equipped with the latest scientific machinery, ingredients, and trained staff supported by SOP. These segments are instrumental testing, chemical testing, pyrogen testing, and Bacterial endotoxin testing and microbiology, etc. The Company had put up a multi-storied factory building in Nag Kalan, Amritsar, which started its production in March 2006. The new factory was as per WHO GMP norms. It put up the Jassur Plant in Himachal Pradesh. This unit was in the TAX-free zone, which has helped the Company to sell its Products into the Indian retail market. Kwality Pharmaceuticals, as an exporting company has supplied Remdesivir Injection to the global market and similarly Propofol injection was short in supply in various high profile countries who normally accept US FDA companies' products. But in shortage of medicine, they procured these injections from the Company and after seeing the performance and efficacy, they registered the product. They started procuring the other items of the Company and it became world recognized and now the booking grew which has yielded more sales and profit for the Company. Throughout the year 2025, Company strengthened its presence across both domestic and international markets. With approvals from leading global regulatory bodies such as EU-GMP, SFDA, INVIMA, ANVISA, among others, it expanded the footprint in over 80 countries.

Parent Organisation
Founded1983
Managing Director
NSE SymbolKPL

Kwality Pharmaceuticals Ltd Resistance and Support levels

R33,627.80R23,574.51R13,541.59S13,435.01S23,402.09S33,348.803,630.30

Kwality Pharmaceuticals Ltd Technicals

Current Price
₹3,630.30 ₹177.90 (+5.15%)
Bearish
0
Bullish
12
  • 20 Day16.7%
  • 50 Day32.1%
  • 100 Day51.3%
  • 200 Day51.3%

Kwality Pharmaceuticals Ltd Latest News

View More
08 AUG 2026 | Saturday
Kwality Pharmaceuticals re-appoints Aditya Arora as Whole Time Director for five years
24 JUL 2026 | Friday
Kwality Pharmaceuticals receives CDSCO approval to manufacture Pembroluzimab for preclinical studies
19 MAY 2026 | Tuesday
Kwality Pharma surges on strong Q4 numbers; PAT jumps 75%
09 MAY 2026 | Saturday
Kwality Pharmaceuticals to conduct board meeting
08 MAY 2026 | Friday
Kwality Pharmaceuticals receives upgrade in credit ratings from ICRA

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced

Frequently asked questions

The share price of Kwality Pharmaceuticals Ltd is ₹3,630.30 as of 21 Aug 2026 at 05:50.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now